hydroxyproline has been researched along with em703 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Azuma, A; Hirata, Y; Inagaki, H; Kawada, T; Kudoh, S; Li, YJ; Matsuda, K; Omura, S; Shimizu, T; Sunazuka, T; Takahashi, S; Usuki, J | 1 |
1 other study(ies) available for hydroxyproline and em703
| Article | Year |
|---|---|
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Topics: Animals; Anti-Inflammatory Agents; Base Sequence; Bleomycin; Cell Line; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression Regulation; Hydroxyproline; Lung; Male; Mice; Mice, Inbred ICR; Molecular Sequence Data; Pulmonary Fibrosis; Smad2 Protein; Smad3 Protein; Smad4 Protein; Transforming Growth Factor beta | 2006 |